Adenosine, an identified active component from the driselase-treated fraction of rice bran, is effective at improving metabolic syndrome in stroke-prone spontaneously hypertensive rats

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 6, 2009, Pages 2558-2564

  Ardiansyah, ^a   Shirakawa, Hitoshi ^a   Shimeno, Taku ^b   Koseki, Takuya ^b   Shiono, Yoshihito ^b   Murayama, Tetsuya ^b   Hatakeyama, Eiko ^c   Komal, Michio ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c TOHOKU FUKUSHI UNIVERSITY   (Japan)

Author keywords

Adenosine; Glucose metabolism; Hepatic gene expression; Hypertension; Lipid profile; Rice bran

Indexed keywords

ADENOSINE; DRISELASE; FUNGAL PROTEIN; GLYCOSIDASE; NITRIC OXIDE; TRIACYLGLYCEROL;

ANIMAL; ARTICLE; BLOOD; CHEMISTRY; GLUCOSE BLOOD LEVEL; HYPERTENSION; ISOLATION AND PURIFICATION; MALE; METABOLIC SYNDROME X; METABOLISM; PLANT SEED; RAT; RICE; SPONTANEOUSLY HYPERTENSIVE RAT;

ADENOSINE; ANIMALS; BLOOD GLUCOSE; FUNGAL PROTEINS; GLYCOSIDE HYDROLASES; HYPERTENSION; MALE; METABOLIC SYNDROME X; NITRIC OXIDE; ORYZA SATIVA; RATS; RATS, INBRED SHR; SEEDS; TRIGLYCERIDES;

RATTUS;

EID: 64549158039     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf803347c     Document Type: Article

References (38)

1. Sakamoto, K.; Tabata, T.; Shirasaki, K.: Inagaki, T.: Nakayama, S. Effects of gamma-oryzanol and cycloartenol ferulic acid ester on cholesterol diet induced hyperlipidemia in rats. Jpn. J. Phar-macol. 1987, 45, 559-565.
2. Purushothama, S.; Raina, P. L.; Hariharan, K. Effect of long-term feeding of rice bran oil upon lipids and lipoproteins in rats. Mol. Cell. Biochem. 1995, 146, 63-69.
3. Berger, A.; Rein, D.; Schafer, A.; Monnard, I.; Gremaud, G.; Lambelet, P.; Bertoli, C. Similar cholesterol-lowering properties of rice bran oil, with varied gamma-oryzanol. in mildly hyperc-holesterolemic men. Eur. J. Nutr. 2005, 44, 163-173.
4. Most, M. M.; Tulley, R.; Morales, S.; Lefevre, M. Rice bran oil, not fiber, lowers cholesterol in humans. Am. J. Clin. Nutr. 2005, 81, 64-68.
5. Saulnier, L.; Thibault, J. F. Ferulic acid and diferulic acids as components of sugar-beet pectins and maize bran heteroxylans. J. Sci. Food Agric. 1999, 79, 396-402.
6. Cheruvanky, R. Bioactive in rice bran and rice bran oil. In Phytochemicals as Bioactive Agents; Bidlack, W. R., Omaye. S. T., Meskin, M. S., Topham, D. K. W., Eds.: Technomic Publishing Company, Inc.: Lancaster, PA, 2000; pp 213-240.
7. Ardiansyah; Shirakawa, H.; Koseki, T.; Ohinata, K.; Hashizume, K.; Komai, M. Rice bran fractions improve blood pressure, lipid profile, and glucose metabolism in stroke-prone spontaneously hypertensive rats. J. Agric. Food Chem. 2006, 54, 1914-1920.
8. Ardiansyah; Shirakawa, H.; Koseki, T.; Hashizume, K.; Komai, M. The Driselase-treated fraction of rice bran is a more effective dietary factor to improve hypertension, glucose and lipid metabolism in stroke-prone spontaneously hypertensive rats compared to ferulic acid. Br. J. Nutr. 2007, 97, 67-76.
9. Motti, A.; Tissot, C: Rimensberger, P. C.; Prina-Rousso, A.; Aggoun, Y.; Berner, M.; Beghetti, M.; Cruz, d. A. Intravenous adenosine for refractory pulmonary hypertension in low-weight premature newborn: A potential new drug for rescue therapy. Pediatr. Crit. Care Med. 2006, 7, 380-382.
10. 2B receptors. Hypertension 2005, 46, 628-634.
11. Jackson, E. K.; Dubey, R. K. Role of the extracellular cAMP-adenosine pathway in renal physiology. Am. J. Physiol. 2001, 28, F597-F612.
12. Olah, S. N.; Stiles, G. L. The role receptor structure in determining adenosine receptor activity. Pharmacol. Ther. 2000, 85, 55-75.
13. Fukumori, Y.; Maeda, N.; Takeda, H.; Onodera, S. Serum glucose and insulin response in rats administered with sucrose or starch containing adenosine, inosine or cytosine. Biosci., Biotechnol, Biochem. 2000, 64, 237-243.
14. Fukumori, Y.; Takeda, H.; Fujisawa, T.; Ushijima, K.; Onodera, S.; Shiomi, N. Blood glucose and insulin concentrations are reduced in human administered sucrose with inosine or adenosine. J. Nutr. 2000, 130, 1946-1949.
15. Wolever, T. M.; Jenkins, D. J. The use of the glycemic index in predicting the blood glucose response to mixed meals. Am. J. Clin. Nutr. 1986, 43, 167-172.
16. Friedewald, W. T.; Levy, R. I.; Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18, 499-502.
17. Folch, J.; Lees, M.; Stanley, G. H. S. A simple method for the isolation and purification of total lipid from animal tissues. J. Biol. Chem. 1957, 226, 497-509.
18. Shirakawa, H.; Ohsaki, Y.; Minegishi, Y.; Takumi, N.; Ohinata, K.; Furukawa, Y.; Mizutani, T.; Komai, M. Vitamin K deficiency reduces testosterone production in the testis through down-regulation of the Cypl la a cholesterol side chain cleavage enzyme in rats. Biochim. Biophys. Acta 2006, 1760, 1482-1488.
19. Collison, M.; Glazier, A. M.; Graham, D.; Morton, J. J.; Dominiczak, M. H.; Aitman, T. J.; Connell, J. M.; Gould, G. W.: Dominiczak, A. F. Cd36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat. Diabetes 2000, 49, 2222-2226.
20. Okamoto, K.; Yamori, Y.; Nagaoka, A. Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ. Res. 1974, 34/35, 143-153.
21. Kibbe, M.; Billiar, T.; Tzeng, E. Inducible nitric oxide synthase and vascular injury. Cardiovasc. Res. 1999, 43, 650-657.
22. Moncada, S.; Higgs, E.; Palmer, R. M. J. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 1991, 43, 109-142.
23. Malinski, T.; Kapturczak, M.; Dayharsh, J.; Bohr, D. Nitric oxide synthase activity in genetic hypertension. Biochem. Biophys. Res. Cmnmun. 1993, 194, 654-658.
24. Hirata, Y.; Hayakawa, H.: Kakoki, M.; Tojo, A.; Suzuki, E.: Kimura, K.; Goto, A.; Kikuchi, K.; Nagano, T.; Hirobe, M.; Omata, M. Nitric oxide release from kidneys of hypertensive rats treated with imidapril. Hypertension 1993, 27, 672-678.
25. Fullerton, D. A.; Agrafojo, J.; Mclntyre, R. C., Jr. Pulmonory vascular smooth muscle relaxation by cAMP-mediated pathways. J. Surg. Res. 1996, 61, 444-448.
26. Saadjiaan, A. Y.; Paganelli, F.; Jui, M. A.; Devaux, C.; Lévy, S.: Guieu, R. P. Plasma beta-endorphin and adenosine concentration in pulmonary hypertension. Am. J. Cardiol. 2000, 85, 858-863.
27. Roman, L. J.; Masters, B. S. S. The cytochromes P450 and nitric oxide synthases. In Textbook of Biochemistry with Clinical Correlations, 6th ed.; Devlin, T. M., Ed.; Willey-Liss: New Jersey, 2006; pp 413-442.
28. Kibbe, M.; Billiar, T.; Tzeng, E. Inducible nitric oxide synthase and vascular injury. Cardiovasc. Res. 1999, 43, 650-657.
29. Moncada, S.; Higgs, E.; Palmer, R. M. J. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 1991, 43, 109-142.
30. Matsuzawa, Y.; Funahashi, T.; Nakamura, T. Molecular mechanism of metabolic syndrome X: Contribution of adipocytokine-sadipocyte-derived bioactive substances. Ann. N. Y. Acad. Sci. 1999, 892, 146-154.
31. Hiraoka-Yamamoto, J.; Nara, Y.; Yasui, N.; Onobashi, Y.; Tsuchikura, S.; Ikeda, K. Establishment of a new animal model of metabolic syndrome: SHRSP fatty (fa/fa) rats. Clin. Exp. Pharmacol. Physiol. 2004, 31, 107-109.
32. Hotta, K.; Funahashi, T.; Bodkin, N. L.; Ortmeyer, H. K.; Arita, Y.; Hansen, B. C.; Matsuzawa, Y. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type-2 diabetes in rhesus monkeys. Diabetes 2001, 50, 1126-1133.
33. Yamauchi, T.; Kamon, J.; Waki, H.; Terauchi, Y.; Kubuto, N.; Hara, K.; Mori, Y.; Ide, T.; Murakami, K.; Tsuboyama-Kasaoka, N.; Ezaki, O.; Akanuma, Y.; Gavrilova, O.; Vinson, C.; Reitman, M. L.; Kagechika, H.; Shudo, K.; Yoda, M.; Nakano, Y.; Tobe, K.; Nagai, R.; Kimura, S.; Tomita, M.; Froguel, P.; Kadowaki, T. The fat derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 2001, 7, 941-946.
34. Berg, A. H.; Combs, T. P.; Du, X.; Brownlee, M.; Sherer, P. E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 2001, 7, 947-953.
35. Maeda, N.; Takahashi, M.; Funahashi, T.; Shinji, K.; Hitoshi, N.: Ken, K.; Hiroyuki, N.; Morihiro, M.; Ryutaro, K.; Noriyuki, O.; Hiroshi, K.; Kikuko, H.; Tadashi, N.; lichiro, S.; Yuji, M. PPARγ ligands increase expression and plasma concentration of adi-ponectin, an adipose-derived protein. Diabetes 2001, 50, 2094-2099.
36. Ouchi, N.; Ohishi, M.; Kihara, S.; Funahashi, T.; Nakamura, T.; Nagaretani, H.; Kumada, M.; Ohashi, K.; Okamoto, Y.; Nishizawa, H.; Kishida, K.; Maeda, N.; Nagasawa, A.; Kobayashi, H.; Hiraoka, H.; Komai, N.; Kaibe, M.; Rakugi, M.; Ogihara, T.; Matsuzawa, Y. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003, 42, 231-234.
37. Fajas, L.; Auboeuf, D.; Raspe, E.; Schoonjans, K.; Lefebvre, A. M.; Saladin, R.; Najib, J.; Laville, M.; Fruchart, J. C.; Deeb, S.; Vidal-Puig, A.; Flier, J.; Briggs, M. R.; Staels, B.; Vidal, H.; Auwerx, J. Organization, promoter analysis and expression of the human PPARγ gene, J. Biol. Chem. 1997, 272, 18779-18789.
38. Lehmann, J. M.; Moore, L. B.; Smith-Oliver, T. A.; Wilkison, W. O.; Willson, T. M.; Kliewer, S. A. An antidiabetic thiazo-lidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 1995, 270, 12953-12956.